@FierceBiotech: Scientists at JHU have developed a virtual tool, Pyromaker, that can aid in analysis of complex genetic mutations. Release | Follow @FierceBiotech
@JohnCFierce: Last week's headlines on mouse study and bexarotene inspired some Alzheimer's patients to ask for an Rx. More | Follow @JohnCFierce
@RyanMFierce: A German drug data firm got slammed for potential privacy violations after selling Big Pharma groups raw script data. Story | Follow @RyanMFierce
@FierceMedDev: J&J could invest in Salt Lake City-based Coherex Medical (Update) (@deseretnews). News | Follow @FierceMedDev
> King of Prussia, PA-based drug developer Treneva said that it has started human testing of a new IV medicine called TRV130 to treat post-surgical pain. Article
> California startup Vytacera Pharma has licensed an experimental cyanide antidote from the University of Minnesota. Report
Pharma News
@FiercePharma: More fallout from Ben Venue's manufacturing snafu: Childhood leukemia drug may run out w/in 2 weeks--NYT. News | Follow @FiercePharma
> Novartis dealt another setback to broader Menveo use. More
> Lonza teams with S. Africa on antiretroviral API plant. Article
> Gene study finds tumor-cell flaw possibly vulnerable to Pfizer, AZ cancer meds. News
> German data provider accused of selling private script info. Story
> Ben Venue's idled plant triggers 'dire' leukemia-drug shortage. Piece
> After dropping ISTA, Valeant nabs another eye-drug company. Item
Medical Device News
> What's next for Stryker after MacMillan's exit? Story
> Nodality, UCB Pharma ink multiyear companion diagnostics deal. Piece
> Is medical tech the answer for Sony? Item
> Court upholds $371M patent decision against W.L. Gore, favoring Bard. Story
> EU seeks greater oversight after breast implant hysteria. Report
> Rogers, Markey seek new life for unpopular pediatric device rule. Article
IT News
> Belgian researchers access CLC bio's sequence analysis software. Story
> EMC to found Russian cloud computing, 'Big Data' hub. More
> Eagle Genomics, Cycle Computing win bid to develop bioinformatics solutions. News
> CRO ESTERN, Nextrials sign software agreement. Article
> German drug data outfit slammed for potential privacy breach. Item
And Finally... The FDA has given a marketing nod to Merck's ($MRK) Zioptan for "reducing elevated intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension," the company announced. Release